Abstract
Human medicines European public assessment report (EPAR): Relistor, methylnaltrexone bromide, Opioid-Related Disorders,Constipation, Date of authorisation: 01/07/2008, Revision: 15, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have